RE:RE:RLV is promissingWell if we're blindly pumping things, here's my spiel. It is a biotech company so it will be explosively good or can crash down. I have been on this board for years and never pumped and the longs here know I am in healthcare/research so I know what I'm talking about.
Here is my pump with years worth of DD and a large portion of my family's fortune invested.
I'm in ATE with >300k shares. YOLO. John Wallace(their scientific chief) is a literal genius. He has devoted his whole life perfecting ulcer reduction medications and come January he will sing his swan song and prove to the world with the phase 2 trial of their lead drug ATB346 that it works. After that, partner up or sell the rights of ATB346 to big pharma for $150M+ then do the same with the second 2 drugs in the pipeline. My 14 cent shares become easily $2.75c shares within the next 2 years. They had a fault in their first phase 1 trial when someone with hepatitis and gallstones lied to get into the trial for money. Had increased liver enzymes and they found out afterwards. They also realized just how potent their new anti inflammatory is. They were approved to continue with trials and in their phase 2a trial discovered they can use 1/6 the dose of their version of naproxen and get DOUBLE the WOMAC pain reduction. WOMAC is a pain reduction scale. Higher the number the higher the reduction in pain. All antibe wanted to do with that double blind trial was price their drug relieved pain as well as aleve and it actually had double the pain reduction. They're doing a phase 2B trial right now results due Q1 2018 to prove their drug causes no ulceration in the stomach which is a massive problem with naproxen and all other non selective cox inhibitors. When they prove they've created an NSAID based off naproxen with double the pain relief, 1/6 The dosage, less blood pressure effects and NO GI effects it will be a world changing drug. The last piece of the puzzle comes together in Q1 I'm so fuking excited lol. Stock has traded sideways for 8 months now after their last PP and investors are finally coming back to it to get in before trial results come out (still on track for Q1 2018).
Here is a video of him talking to a bunch of doctors presenting their science behind the drug and their journey in the trials thus far. It's not presented pumping it to a bunch of hedgies for money which is why it's such a great video to watch.
https://www.youtube.com/watch?v=w_3heP7ol0A&t
Like anything do your own DD and calculate if it's worth it. Biotech is risky but I think this opportunity is too good to slide by. Good luck